🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 2 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 31/05/2000 | 0,2767 USD |
| 01/03/2000 | 0,2767 USD |
| 01/12/1999 | 0,2767 USD |
| 01/09/1999 | 0,2767 USD |
| 02/06/1999 | 0,2576 USD |
| 03/03/1999 | 0,2576 USD |
| 02/12/1998 | 0,2576 USD |
| 02/09/1998 | 0,2576 USD |
| 03/06/1998 | 0,2147 USD |
| 04/03/1998 | 0,2147 USD |
| 03/12/1997 | 0,2147 USD |
| 03/09/1997 | 0,2147 USD |
| 05/06/1997 | 0,2004 USD |
| 05/03/1997 | 0,2004 USD |
| 05/12/1996 | 0,1908 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 20/08/2019 | 82,07 | 82,76 | 81,66 | 81,73 | -0,63% | 1,34% | 6.176.598 |
| 19/08/2019 | 81,67 | 82,57 | 81,54 | 82,24 | +1,33% | 1,26% | 7.655.221 |
| 16/08/2019 | 80,58 | 81,45 | 80,30 | 81,16 | +1,92% | 1,43% | 9.156.271 |
| 15/08/2019 | 79,69 | 80,01 | 79,09 | 79,64 | +0,07% | 1,15% | 9.543.612 |
| 14/08/2019 | 81,46 | 81,91 | 79,53 | 79,58 | -3,11% | 2,92% | 11.411.148 |
| 13/08/2019 | 81,55 | 82,81 | 81,55 | 82,14 | +1,25% | 1,56% | 8.413.658 |
| 12/08/2019 | 81,33 | 81,99 | 80,65 | 81,13 | -0,58% | 1,65% | 8.761.909 |
| 09/08/2019 | 81,20 | 82,17 | 80,83 | 81,60 | +0,93% | 1,65% | 8.968.260 |
| 08/08/2019 | 80,87 | 81,15 | 80,46 | 80,85 | +0,57% | 0,86% | 8.699.762 |
| 07/08/2019 | 80,35 | 80,81 | 79,01 | 80,39 | -0,12% | 2,24% | 11.509.660 |
| 06/08/2019 | 79,31 | 80,61 | 79,29 | 80,49 | +1,48% | 1,66% | 11.025.274 |
| 05/08/2019 | 80,01 | 80,48 | 78,40 | 79,31 | -1,60% | 2,60% | 11.885.578 |
| 02/08/2019 | 80,04 | 80,89 | 79,72 | 80,60 | +0,93% | 1,45% | 10.913.767 |
| 01/08/2019 | 79,26 | 80,63 | 78,86 | 79,86 | +0,84% | 2,24% | 10.550.006 |
| 31/07/2019 | 79,10 | 80,77 | 79,05 | 79,19 | -0,34% | 2,18% | 12.443.428 |
| 30/07/2019 | 80,14 | 81,27 | 79,03 | 79,46 | +0,95% | 2,80% | 14.286.965 |
| 29/07/2019 | 78,34 | 79,01 | 77,87 | 78,71 | +1,30% | 1,45% | 11.123.682 |
| 26/07/2019 | 77,84 | 77,89 | 77,20 | 77,70 | -0,39% | 0,88% | 7.638.977 |
| 25/07/2019 | 77,72 | 79,26 | 77,34 | 78,01 | +0,00% | 2,47% | 9.670.106 |
| 24/07/2019 | 78,24 | 78,54 | 77,40 | 78,01 | -0,34% | 1,45% | 7.720.197 |
| 23/07/2019 | 77,75 | 78,65 | 77,19 | 78,27 | +1,01% | 1,89% | 7.420.469 |
| 22/07/2019 | 77,94 | 78,07 | 77,34 | 77,49 | -0,22% | 0,94% | 7.261.697 |
| 19/07/2019 | 78,91 | 79,03 | 77,43 | 77,66 | -1,57% | 2,02% | 12.053.782 |
| 18/07/2019 | 78,64 | 79,16 | 77,86 | 78,90 | +0,94% | 1,65% | 8.472.661 |
| 17/07/2019 | 78,21 | 78,57 | 77,84 | 78,17 | +0,40% | 0,93% | 9.848.999 |
| 16/07/2019 | 77,60 | 78,03 | 77,19 | 77,85 | +0,78% | 1,09% | 8.448.662 |
| 15/07/2019 | 76,91 | 77,55 | 76,45 | 77,25 | +1,54% | 1,43% | 10.922.570 |
| 12/07/2019 | 77,15 | 77,19 | 75,03 | 76,08 | -1,57% | 2,81% | 18.910.636 |
| 11/07/2019 | 79,68 | 79,84 | 76,13 | 77,29 | -4,50% | 4,66% | 22.146.126 |
| 10/07/2019 | 80,92 | 81,21 | 80,49 | 80,94 | -0,05% | 0,90% | 5.996.132 |